Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Pfizer's Rita Balice-Gordon to lead neurobiology research

She will be based at the firm's Framingham, Massachusetts R&D site

Sanofi Rita Balice-GordonSanofi has appointed Rita Balice-Gordon as head of its neurobiology research therapeutic area.

She joins the French pharma firm from Pfizer, where she served as head of circuits, neurotransmitters and signaling in the its neuroscience and pain research unit.

During her time there she led a global team and was responsible for the company's worldwide research and development postdoctoral programme.

Prior to her time at Pfizer Balice-Gordon was professor of neuroscience and chair of the neuroscience graduate group in the Perelman School of Medicine at the University of Pennsylvania, where she currently holds an adjunct appointment.

In her new role at Sanofi Balice-Gordon will based at the firm's Framingham, Massachusetts R&D site and lead research efforts associated with Sanofi's early portfolio in neurobiology, including neurodegeneration, neuroinflammation and central nervous system inherited diseases.

18th May 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics